TrialPloS one2022

Association of C-peptide and lipoprotein(a) as two predictors with cardiometabolic biomarkers in patients with type 2 diabetes in KERCADR population-based study.

Mohammad Reza Mahmoodi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.